The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non–small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non–small cell lung cancer

Published:1986-03 Issue:3 Volume:91 Page:344-349
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Ferguson Mark K.,Little Alex G.,Golomb Harvey M.,Hoffman Philip C.,DeMeester Tom R.,Beveridge Roy,Skinner David B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference14 articles.

1. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma;Newman;J Thorac Cardiovasc Surg,1983

2. Prognostic significance of Nl disease in carcinoma of the lung;Martini;J Thorac Cardiovasc Surg,1983

3. American Joint Committee for Cancer Staging and End-Results Reporting. Manual for Staging of Lung Cancer,1979

4. A computer program for comapring k samples with right-censored data;Lee;Comput Programs Biomed,1972

5. Nonparametric estimation from incomplete observations;Kaplan;J Am Stat Assoc,1958

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of vascular and lymphovascular invasion in early lung cancer;Asian Cardiovascular and Thoracic Annals;2013-09-04

2. Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung;Journal of Thoracic Oncology;2007-12

3. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer;Journal of Thoracic Oncology;2007-07

4. A Phase II Study of Concurrent Carboplatin and Paclitaxel and Thoracic Radiotherapy for Completely Resected Stage II and IIIA Non-small Cell Lung Cancer;Journal of Thoracic Oncology;2007-04

5. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis;Lung Cancer;2005-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3